This inventor holds 4 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1979-1992.
Location History:
- Minoh, JP (1984)
- Minoo, JP (1979 - 1992)
Company Filing History:
Years Active: 1979-1992
Title: Shigeru Nishimoto: Innovator in Pharmaceutical Chemistry
Introduction
Shigeru Nishimoto is a notable inventor based in Minoo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for preparing benzothiazepine derivatives. With a total of 4 patents to his name, Nishimoto's work has implications for various pharmaceutical applications.
Latest Patents
Nishimoto's latest patents include a process for preparing 1,5-benzothiazepine derivatives. This disclosure describes a method that utilizes sulfonic acids as catalysts to facilitate the ring closure necessary for forming the 1,5-benzothiazepinone ring. The resulting compounds are recognized for their well-known pharmaceutical properties. Another patent details a process for preparing 1,5-benzothiazepine derivatives, represented by a specific chemical formula. This process involves an intramolecular ring closing reaction in the presence of a sulfonic acid compound, which plays a crucial role in the synthesis of these derivatives.
Career Highlights
Shigeru Nishimoto is associated with Tanabe Seiyaku Company, Limited, where he has been able to apply his expertise in pharmaceutical chemistry. His innovative approaches have contributed to the advancement of drug development processes, enhancing the efficacy of various pharmaceutical compounds.
Collaborations
Nishimoto has worked alongside notable colleagues such as Hiroyuki Nate and Yasuji Ikeda. Their collaborative efforts have further enriched the research and development environment at Tanabe Seiyaku Company, Limited.
Conclusion
Shigeru Nishimoto's contributions to pharmaceutical chemistry through his innovative patents and collaborative work highlight his importance in the field. His ongoing research continues to pave the way for advancements in drug development and therapeutic applications.